Natco Pharma

889.25

-13.60 (-1.51%) tick

NSE

Buy Sell

NSE BSE

Last updated on 25 Apr 2025 03:33 PM

Open Demat account

Returns

7.31%

Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

16185.26

Earning Per Share

72.99

Dividend Yield

P/E Ratio

13.04

P/B Ratio

2.37

Debt to Equity

0.05

Performance

min-value

max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value

max-value

5.34% down side

up side5.34%

About the company

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs). The Company's focus is primarily on niche therapeutic areas and complex products. It sells products in over 40 countries. FDF products are sold in the United States, India, Europe and the rest of the world (RoW). Natco's API products are primarily used for captive consumption in its FDF products and are also sold to customers for various international markets such as Brazil, Europe and USA.

Similar Companies

Laurus Labs

623.1 -22.40 (-0.03%) tick

1Yr Returns

+51.56%

Suven Pharmaceuticals

1145 -59.80 (-0.05%) tick

1Yr Returns

+86.27%

Piramal Pharma Limited

216.25 -3.62 (-0.02%) tick

1Yr Returns

+54.89%

J.B.Chemicals & Pharma

1573.7 -35.40 (-0.02%) tick

1Yr Returns

-13.61%

Wockhardt

1389.9 -75.30 (-0.05%) tick

1Yr Returns

+156.75%